Explore more publications!

The Georgian Health Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Georgian Health Digest.

Press releases published on December 4, 2025

Philips reiterates timing of 2026 outlook
uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025 Cannabis Holiday Gift Guide Highlights Canada’s Most Popular Cannabis Products for the Holiday Season
Microbix Announces Initiation of Normal Course Issuer Bid
Denali Therapeutics and Royalty Pharma Announce $275 Million Royalty Funding Agreement
MapLight Therapeutics Reports Third Quarter Financial Results and Highlights Corporate Progress
Vaxil Announces Close of Previously Announced Non-Brokered Private Placement and Update on Board of Directors
RadioMedix and Thor Medical enter supply agreement for thorium-228
Crescent Biopharma Announces Transformational Partnership with Kelun-Biotech and $185 Million Private Placement, Accelerating and Expanding Global Pipeline of Next Generation Therapeutics for Solid Tumors
Merakris Therapeutics Announces Completion of Type C Meeting with FDA – Alignment on MTX-001 Biologic Drug Development Pathway
Kelun-Biotech and Crescent Biopharma Announce Strategic Partnership to Develop and Commercialize Novel Oncology Therapeutics
Communiqué de presse : Sanofi finalise l’acquisition de Vicebio
Press Release: Sanofi completes acquisition of Vicebio
Sapu Nano 推出具有广泛应用前景的 Deciparticle™ 纳米药物平台,可用于多种疏水性肽类、大环内酯类和聚酮类药物的制剂化
Sapu Nano 推出具有廣泛適用性的 Deciparticle™ 納米醫學平台,能夠製備多種疏水性胜肽類、大環內酯類和聚酮類藥物
Laigo Bio raises €11.5 million in seed financing to advance its SureTAC™ targeted protein degradation candidates in oncology and auto-immunity
The Hemp Doctor Introduces THCA Flower Subscription Box — Monthly Curated Rotating Strains, Pre-Rolls & Extras
Hapbee Appoints Hasan Shahid to Board of Directors to Strengthen Capital Markets & Strategic Growth Capabilities
Axogen Announces FDA Approval of Biologics License Application for AVANCE® (acellular nerve allograft–arwx)

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions